Skip to content
Trial Eligibility
Menu

Multiple Sclerosis Clinical Trials near New York, NY

30 studies for Multiple Sclerosis are recruiting at 42 sites within 50 miles of New York, New York, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Multiple Sclerosis trials in the US or all trials near New York.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Multiple Sclerosis studies enrolling near New York

Showing 30 studies, nearest first.
  1. A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

    NCT06433752

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: TG Therapeutics Investigational Trial Site (New York, NY); TG Therapeutics Investigational Trial Site (Teaneck, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  3. Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

    NCT05877963

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: TG Therapeutics Investigational Trial Site (New York, NY); TG Therapeutics Investigational Trial Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. A Palliative Care Model Impact on Knowledge and Attitudes

    NCT06860932

    • Interventional
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: Hunter College (New York, NY); Judith Jaffe Multiple Sclerosis Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

    NCT07224373

    • Phase 1
    • Ages 18 to 60 years
    • Sex: All

    Nearest sites: Research Site (New York, NY); Research Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. Genes and Environment in Multiple Sclerosis

    NCT01353547

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Columbia University Irving Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

    NCT04047628

    • Phase 3
    • Ages 18 to 55 years
    • Sex: All

    Nearest site: Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Siinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Vancomycin Study in Multiple Sclerosis (MS)

    NCT05539729

    • Phase 1
    • Ages 18 to 50 years
    • Sex: All

    Nearest site: Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

    NCT05982925

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Mount Sinai Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Effect of Cooling on Balance Performance in Multiple Sclerosis

    NCT06094855

    • Observational
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Hunter College, Physical Therapy Department, City University of New York (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. NYSCF Scientific Discovery Biobank

    NCT06203106

    • Observational
    • Ages 30 days and older
    • Sex: All

    Nearest site: New York Stem Cell Foundation Research Institute (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Eccentric Exercise and Fatigue in Multiple Sclerosis

    NCT06505421

    • Observational
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Hunter College, Physical Therapy Department, City University of New York (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

    NCT06680037

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: TG Therapeutics Investigational Trial Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

    NCT06901687

    • Phase 2
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study of the MIND Diet for Persons With Multiple Sclerosis

    NCT06992115

    • Interventional
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Mount Sinai Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

    NCT07002034

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

    NCT07299019

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Mount Sinai Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

    NCT07304154

    • Phase 1
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Columbia University Irving Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

    NCT07477639

    • Phase 1/2
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Mt. Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

    NCT07497399

    • Phase 2
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Mount Sinai School of Medicine (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

    NCT06846281

    • Phase 3
    • Ages 40 to 70 years
    • Sex: All

    Nearest site: Holy Name Medical Center (Teaneck, NJ)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

    NCT07325292

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Holy Name Medical Center- Site Number : 8400101 (Teaneck, NJ)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

    NCT04855825

    • Interventional
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Kessler Foundation (West Orange, NJ)

    Distance to nearest recruiting site
    ~14 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

    NCT07067463

    • Phase 3
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Cooperman Barnabas Medical Center (Livingston, NJ)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis

    NCT06197685

    • Interventional
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Kessler Foundation (East Hanover, NJ)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community

    NCT06608797

    • Interventional
    • Ages 19 to 65 years
    • Sex: All

    Nearest site: Kessler Foundation (East Hanover, NJ)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

    NCT07779460

    • Observational
    • Ages 18 to 100 years
    • Sex: All

    Nearest site: Novartis (East Hanover, NJ)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

    NCT07614321

    • Phase 4
    • Ages 18 years and older
    • Sex: Female

    Nearest site: Atlantic Health (Morristown, NJ)

    Distance to nearest recruiting site
    ~26 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Neurologic Stem Cell Treatment Study

    NCT02795052

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: MD Stem Cells (Westport, CT)

    Distance to nearest recruiting site
    ~45 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

    NCT07732907

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Bristol Myers Squibb (Lawrenceville, NJ)

    Distance to nearest recruiting site
    ~48 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Multiple Sclerosis clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.